TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10969853
log Bayes Factor = <0.0001
Chromosome 9   position 30,751,220  (GRCh37) Explore rs10969853 on Ensembl!
Variant rs10969853 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
I21.1 Acute transmural myocardial infarction of inferior wall
0.000 0.987 0.013
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
0.008 0.992 0.000
N03.9 Unspecified
0.000 0.993 0.007
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess
0.007 0.993 0.000
R03.0 Elevated blood-pressure reading, without diagnosis of hypertension
0.000 0.995 0.005
Y42.5 Other oestrogens and progestogens
0.005 0.995 0.000
D51 Vitamin B12 deficiency anaemia
0.005 0.995 0.000
N03 Chronic nephritic syndrome
0.000 0.996 0.004
D51.9 Vitamin B12 deficiency anaemia, unspecified
0.004 0.996 0.000
H53.1 Subjective visual disturbances
0.004 0.996 0.000
D51.8 Other vitamin B12 deficiency anaemias
0.003 0.996 0.000
D51.3 Other dietary vitamin B12 deficiency anaemia
0.003 0.996 0.000
D51.2 Transcobalamin II deficiency
0.003 0.996 0.000
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria
0.003 0.996 0.000
Y42.7 Androgens and anabolic congeners
0.003 0.996 0.000
Q21.1 Atrial septal defect
0.000 0.996 0.003
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.003 0.996 0.000
K75.4 Autoimmune hepatitis
0.003 0.997 0.000
K75.8 Other specified inflammatory liver diseases
0.003 0.997 0.000
K75 Other inflammatory liver diseases
0.003 0.997 0.000
K75.9 Inflammatory liver disease, unspecified
0.003 0.997 0.000
Z08.0 Follow-up examination after surgery for malignant neoplasm
0.003 0.997 0.000
N03.8 Other
0.000 0.997 0.003
N03.7 Diffuse crescentic glomerulonephritis
0.000 0.997 0.003
N03.6 Dense deposit disease
0.000 0.997 0.003
N03.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.997 0.003
N03.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.997 0.003
N03.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.997 0.003
N03.2 Diffuse membranous glomerulonephritis
0.000 0.997 0.003
N03.1 Focal and segmental glomerular lesions
0.000 0.997 0.003
N03.0 Minor glomerular abnormality
0.000 0.997 0.003
I63.9 Cerebral infarction, unspecified
0.000 0.997 0.003
N45 Orchitis and epididymitis
0.003 0.997 0.000
Z30.1 Insertion of (intra-uterine) contraceptive device
0.003 0.997 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.003 0.997 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.003 0.997 0.000
Z30.2 Sterilisation
0.003 0.997 0.000
S22.30 Fracture of rib (closed)
0.003 0.997 0.000
S82.20 Fracture of shaft of tibia (closed)
0.000 0.997 0.003
K75.0 Abscess of liver
0.003 0.997 0.000
Y42.9 Other and unspecified hormone antagonists
0.003 0.997 0.000
Y42.4 Oral contraceptives
0.003 0.997 0.000
Y42.2 Antithyroid drugs
0.003 0.997 0.000
Y42.1 Thyroid hormones and substitutes
0.003 0.997 0.000
K83.8 Other specified diseases of biliary tract
0.000 0.997 0.003
R03 Abnormal blood-pressure reading, without diagnosis
0.000 0.997 0.003
E66.8 Other obesity
0.003 0.997 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.003 0.997 0.000
K75.3 Granulomatous hepatitis, not elsewhere classified
0.002 0.997 0.000
K75.2 Nonspecific reactive hepatitis
0.002 0.997 0.000
K75.1 Phlebitis of portal vein
0.002 0.997 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.002 0.997 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.003 0.997 0.000
Y45.1 Salicylates
0.002 0.997 0.000
E11.2 With renal complications
0.000 0.998 0.002
R03.1 Nonspecific low blood-pressure reading
0.000 0.998 0.002
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess
0.002 0.998 0.000
Y45.8 Other analgesics and antipyretics
0.002 0.998 0.000
O02.1 Missed abortion
0.000 0.998 0.002
T18.1 Foreign body in oesophagus
0.000 0.998 0.002
Z30 Contraceptive management
0.002 0.998 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.002 0.998 0.000
N19 Unspecified renal failure
0.000 0.998 0.002
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.002 0.998 0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device
0.002 0.998 0.000
T39.0 Salicylates
0.002 0.998 0.000
Z43.2 Attention to ileostomy
0.002 0.998 0.000
J90 Pleural effusion, not elsewhere classified
0.002 0.998 0.000
W19.4 Street and highway
0.000 0.998 0.002
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.002 0.998 0.000
Y45.5 4-Aminophenol derivatives
0.002 0.998 0.000
Y45.4 Antirheumatics
0.002 0.998 0.000
E11.3 With ophthalmic complications
0.000 0.998 0.002
Y45.2 Propionic acid derivatives
0.002 0.998 0.000
Z34.8 Supervision of other normal pregnancy
0.000 0.998 0.002
Z30.9 Contraceptive management, unspecified
0.002 0.998 0.000
Z30.8 Other contraceptive management
0.002 0.998 0.000
Z30.4 Surveillance of contraceptive drugs
0.002 0.998 0.000
Y49.2 Other and unspecified antidepressants
0.002 0.998 0.000
Q21 Congenital malformations of cardiac septa
0.000 0.998 0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.002 0.998 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.002 0.998 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.002 0.998 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
N81.3 Complete uterovaginal prolapse
0.000 0.998 0.002
H66.9 Otitis media, unspecified
0.002 0.998 0.000
Z08.7 Follow-up examination after combined treatment for malignant neoplasm
0.002 0.998 0.000
Z30.0 General counselling and advice on contraception
0.002 0.998 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.002 0.998 0.000
E11.4 With neurological complications
0.000 0.998 0.002
J39.2 Other diseases of pharynx
0.000 0.998 0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.002 0.998 0.000
T43.2 Other and unspecified antidepressants
0.002 0.998 0.000
Z30.3 Menstrual extraction
0.002 0.998 0.000
Z34.9 Supervision of normal pregnancy, unspecified
0.000 0.998 0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
K83 Other diseases of biliary tract
0.000 0.998 0.002
Y47 Sedatives, hypnotics and antianxiety drugs
0.002 0.998 0.000
I95.9 Hypotension, unspecified
0.000 0.998 0.002
S22.3 Fracture of rib
0.002 0.998 0.000
E11.1 With ketoacidosis
0.000 0.998 0.002
K83.0 Cholangitis
0.000 0.998 0.002
Y41 Other systemic anti-infectives and antiparasitics
0.002 0.998 0.000
Q21.9 Congenital malformation of cardiac septum, unspecified
0.000 0.998 0.001
Q21.8 Other congenital malformations of cardiac septa
0.000 0.998 0.001
Q21.4 Aortopulmonary septal defect
0.000 0.998 0.001
Q21.3 Tetralogy of Fallot
0.000 0.998 0.001
Q21.2 Atrioventricular septal defect
0.000 0.998 0.001
T36.0 Penicillins
0.002 0.998 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.002 0.998 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.002 0.998 0.000
T39.4 Antirheumatics, not elsewhere classified
0.002 0.998 0.000
T39.2 Pyrazolone derivatives
0.002 0.998 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.002 0.998 0.000
Y59 Other and unspecified vaccines and biological substances
0.002 0.998 0.000
Y58 Bacterial vaccines
0.002 0.998 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.002 0.998 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.002 0.998 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.002 0.998 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.002 0.998 0.000
Y48 Anaesthetics and therapeutic gases
0.002 0.998 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.002 0.998 0.000
Q21.0 Ventricular septal defect
0.000 0.998 0.001
Y49.9 Psychotropic drug, unspecified
0.001 0.998 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.001 0.998 0.000
Y49.7 Psychostimulants with abuse potential
0.001 0.998 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.001 0.998 0.000
Y49.5 Other antipsychotics and neuroleptics
0.001 0.998 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.001 0.998 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.001 0.998 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.001 0.998 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.001 0.998 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.002 0.998 0.000
Y57 Other and unspecified drugs and medicaments
0.002 0.998 0.000
D50-D53 Nutritional anaemias
0.002 0.998 0.000
F10.0 Acute intoxication
0.000 0.998 0.002
T31.0 Burns involving less than 10% of body surface
0.002 0.998 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.002 0.998 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.998 0.002
T36 Poisoning by systemic antibiotics
0.002 0.998 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.002 0.998 0.000
N08.3 Glomerular disorders in diabetes mellitus
0.000 0.998 0.002
J93.0 Spontaneous tension pneumothorax
0.002 0.998 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.002 0.998 0.000
M25.86 Other specified joint disorders (Lower leg)
0.002 0.998 0.000
C45.0 Mesothelioma of pleura
0.002 0.998 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.001 0.998 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.001 0.998 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.001 0.998 0.000
Y47.1 Benzodiazepines
0.001 0.998 0.000
G35 Multiple sclerosis
0.000 0.998 0.002
J80 Adult respiratory distress syndrome
0.002 0.998 0.000
E11.6 With other specified complications
0.000 0.998 0.002
K83.1 Obstruction of bile duct
0.000 0.998 0.002
N18.0 End-stage renal disease
0.000 0.998 0.002
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.001 0.998 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.001 0.998 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.001 0.998 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.001 0.998 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.001 0.998 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.001 0.998 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.001 0.998 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.001 0.998 0.000
Y51.0 Anticholinesterase agents
0.001 0.998 0.000
D52 Folate deficiency anaemia
0.001 0.998 0.000
E21.0 Primary hyperparathyroidism
0.002 0.998 0.000
O02.0 Blighted ovum and nonhydatidiform mole
0.000 0.998 0.001
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.001 0.998 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.001 0.998 0.000
T47.7 Emetics
0.001 0.998 0.000
T47.6 Antidiarrhoeal drugs
0.001 0.998 0.000
T47.5 Digestants
0.001 0.998 0.000
T47.4 Other laxatives
0.001 0.998 0.000
T47.3 Saline and osmotic laxatives
0.001 0.998 0.000
T47.2 Stimulant laxatives
0.001 0.998 0.000
T47.0 Histamine H(2)-receptor antagonists
0.001 0.998 0.000
Y45.0 Opioids and related analgesics
0.001 0.998 0.000
Y57.8 Other drugs and medicaments
0.001 0.998 0.000
Z43.3 Attention to colostomy
0.002 0.998 0.000
D53 Other nutritional anaemias
0.001 0.998 0.000
O02 Other abnormal products of conception
0.000 0.998 0.002
H92.1 Otorrhoea
0.001 0.998 0.000
K83.9 Disease of biliary tract, unspecified
0.000 0.998 0.001
K83.5 Biliary cyst
0.000 0.998 0.001
K83.4 Spasm of sphincter of Oddi
0.000 0.998 0.001
K83.3 Fistula of bile duct
0.000 0.998 0.001
K83.2 Perforation of bile duct
0.000 0.998 0.001
T43.9 Psychotropic drug, unspecified
0.001 0.998 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.001 0.998 0.000
T43.6 Psychostimulants with abuse potential
0.001 0.998 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.001 0.998 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.001 0.998 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.001 0.998 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.001 0.998 0.000
Y47.4 Bromine compounds
0.001 0.998 0.000
Y47.3 Paraldehyde
0.001 0.998 0.000
Y47.2 Chloral derivatives
0.001 0.998 0.000
Y47.0 Barbiturates, not elsewhere classified
0.001 0.998 0.000
T18 Foreign body in alimentary tract
0.000 0.998 0.001
S22.31 Fracture of rib (open)
0.001 0.998 0.000
D52.9 Folate deficiency anaemia, unspecified
0.001 0.998 0.000
J93.1 Other spontaneous pneumothorax
0.001 0.998 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.001 0.998 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.001 0.998 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.001 0.998 0.000
Y41.5 Antiviral drugs
0.001 0.998 0.000
Y41.4 Anthelminthics
0.001 0.998 0.000
Y41.3 Other antiprotozoal drugs
0.001 0.998 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.001 0.998 0.000
Y41.1 Antimycobacterial drugs
0.001 0.998 0.000
Y41.0 Sulphonamides
0.001 0.998 0.000
Z43.1 Attention to gastrostomy
0.001 0.998 0.000
Z43 Attention to artificial openings
0.002 0.998 0.000
N17.9 Acute renal failure, unspecified
0.000 0.999 0.001
Y46.8 Antispasticity drugs
0.001 0.999 0.000
Y46.7 Anti-Parkinsonism drugs
0.001 0.999 0.000
Y46.6 Other and unspecified antiepileptics
0.001 0.999 0.000
Y46.5 Valproic acid
0.001 0.999 0.000
Y46.4 Iminostilbenes
0.001 0.999 0.000
Y46.3 Deoxybarbiturates
0.001 0.999 0.000
Y46.2 Hydantoin derivatives
0.001 0.999 0.000
Y46.1 Oxazolidinediones
0.001 0.999 0.000
Y46.0 Succinimides
0.001 0.999 0.000
Y48.5 Therapeutic gases
0.001 0.999 0.000
Y48.4 Anaesthetic, unspecified
0.001 0.999 0.000
Y48.3 Local anaesthetics
0.001 0.999 0.000
Y48.2 Other and unspecified general anaesthetics
0.001 0.999 0.000
Y48.1 Parenteral anaesthetics
0.001 0.999 0.000
Y48.0 Inhaled anaesthetics
0.001 0.999 0.000
Y50.9 Central nervous system stimulant, unspecified
0.001 0.999 0.000
Y50.8 Other central nervous system stimulants
0.001 0.999 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.001 0.999 0.000
Y50.1 Opioid receptor antagonists
0.001 0.999 0.000
Y50.0 Analeptics
0.001 0.999 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.001 0.999 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.001 0.999 0.000
Y53.7 Emetics
0.001 0.999 0.000
Y53.6 Antidiarrhoeal drugs
0.001 0.999 0.000
Y53.5 Digestants
0.001 0.999 0.000
Y53.4 Other laxatives
0.001 0.999 0.000
Y53.3 Saline and osmotic laxatives
0.001 0.999 0.000
Y53.2 Stimulant laxatives
0.001 0.999 0.000
Y53.0 Histamine H2-receptor antagonists
0.001 0.999 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.001 0.999 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.001 0.999 0.000
Y55.5 Anticommon cold drugs
0.001 0.999 0.000
Y55.4 Expectorants
0.001 0.999 0.000
Y55.3 Antitussives
0.001 0.999 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.001 0.999 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.001 0.999 0.000
Y55.0 Oxytocic drugs
0.001 0.999 0.000
Y56.9 Topical agent, unspecified
0.001 0.999 0.000
Y56.8 Other topical agents
0.001 0.999 0.000
Y56.7 Dental drugs, topically applied
0.001 0.999 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.001 0.999 0.000
Y56.5 Ophthalmological drugs and preparations
0.001 0.999 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.001 0.999 0.000
Y56.3 Emollients, demulcents and protectants
0.001 0.999 0.000
Y56.2 Local astringents and local detergents
0.001 0.999 0.000
Y56.1 Antipruritics
0.001 0.999 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.001 0.999 0.000
Y57.9 Drug or medicament, unspecified
0.001 0.999 0.000
Y58.9 Other and unspecified bacterial vaccines
0.001 0.999 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.001 0.999 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.001 0.999 0.000
Y58.5 Diphtheria vaccine
0.001 0.999 0.000
Y58.4 Tetanus vaccine
0.001 0.999 0.000
Y58.3 Plague vaccine
0.001 0.999 0.000
Y58.2 Cholera vaccine
0.001 0.999 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.001 0.999 0.000
Y58.0 BCG vaccine
0.001 0.999 0.000
Y59.9 Vaccine or biological substance, unspecified
0.001 0.999 0.000
Y59.8 Other specified vaccines and biological substances
0.001 0.999 0.000
Y59.3 Immunoglobulin
0.001 0.999 0.000
Y59.2 Protozoal vaccines
0.001 0.999 0.000
Y59.1 Rickettsial vaccines
0.001 0.999 0.000
Y59.0 Viral vaccines
0.001 0.999 0.000
Z02.8 Other examinations for administrative purposes
0.001 0.999 0.000
Y44 Agents primarily affecting blood constituents
0.001 0.999 0.000
Y40 Systemic antibiotics
0.001 0.999 0.000
D53.9 Nutritional anaemia, unspecified
0.001 0.999 0.000
E11.8 With unspecified complications
0.000 0.999 0.001
E11.7 With multiple complications
0.000 0.999 0.001
H04.5 Stenosis and insufficiency of lachrymal passages
0.001 0.999 0.000
K05.3 Chronic periodontitis
0.001 0.999 0.000
T36.9 Systemic antibiotic, unspecified
0.001 0.999 0.000
T36.8 Other systemic antibiotics
0.001 0.999 0.000
T36.7 Antifungal antibiotics, systemically used
0.001 0.999 0.000
T36.6 Rifamycins
0.001 0.999 0.000
T36.5 Aminoglycosides
0.001 0.999 0.000
T36.4 Tetracyclines
0.001 0.999 0.000
T36.3 Macrolides
0.001 0.999 0.000
T36.2 Chloramphenicol group
0.001 0.999 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.001 0.999 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.001 0.999 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.001 0.999 0.000
T46.7 Peripheral vasodilators
0.001 0.999 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.001 0.999 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.001 0.999 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.001 0.999 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.001 0.999 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.001 0.999 0.000
Y57.7 Vitamins, not elsewhere classified
0.001 0.999 0.000
Y57.6 Other diagnostic agents
0.001 0.999 0.000
Y57.4 Pharmaceutical excipients
0.001 0.999 0.000
Y57.3 Alcohol deterrents
0.001 0.999 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.001 0.999 0.000
Y57.1 Lipotropic drugs
0.001 0.999 0.000
Y57.0 Appetite depressants [anorectics]
0.001 0.999 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.001 0.999 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.001 0.999 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.001 0.999 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.001 0.999 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.001 0.999 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.001 0.999 0.000
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
0.001 0.999 0.000
T46.1 Calcium-channel blockers
0.001 0.999 0.000
Y40.0 Penicillins
0.001 0.999 0.000
J93 Pneumothorax
0.001 0.999 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.001 0.999 0.000
Z34 Supervision of normal pregnancy
0.000 0.999 0.001
D52.8 Other folate deficiency anaemias
0.001 0.999 0.000
D52.1 Drug-induced folate deficiency anaemia
0.001 0.999 0.000
D52.0 Dietary folate deficiency anaemia
0.001 0.999 0.000
D05.9 Carcinoma in situ of breast, unspecified
0.001 0.999 0.000
D53.8 Other specified nutritional anaemias
0.001 0.999 0.000
D53.2 Scorbutic anaemia
0.001 0.999 0.000
D53.1 Other megaloblastic anaemias, not elsewhere classified
0.001 0.999 0.000
D53.0 Protein deficiency anaemia
0.001 0.999 0.000
O02.9 Abnormal product of conception, unspecified
0.000 0.999 0.001
O02.8 Other specified abnormal products of conception
0.000 0.999 0.001
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.001 0.999 0.000
C45.9 Mesothelioma, unspecified
0.001 0.999 0.000
G45.9 Transient cerebral ischaemic attack, unspecified
0.001 0.999 0.000
K01.1 Impacted teeth
0.001 0.999 0.000
K74.0 Hepatic fibrosis
0.001 0.999 0.000
T18.9 Foreign body in alimentary tract, part unspecified
0.000 0.999 0.001
T18.8 Foreign body in other and multiple parts of alimentary tract
0.000 0.999 0.001
T18.5 Foreign body in anus and rectum
0.000 0.999 0.001
T18.4 Foreign body in colon
0.000 0.999 0.001
T18.3 Foreign body in small intestine
0.000 0.999 0.001
T18.2 Foreign body in stomach
0.000 0.999 0.001
T18.0 Foreign body in mouth
0.000 0.999 0.001
N17 Acute renal failure
0.000 0.999 0.001
C45.7 Mesothelioma of other sites
0.001 0.999 0.000
I67.2 Cerebral atherosclerosis
0.000 0.999 0.001
L03.9 Cellulitis, unspecified
0.000 0.999 0.001
Y54.9 Mineral salts, not elsewhere classified
0.001 0.999 0.000
Y54.8 Agents affecting uric acid metabolism
0.001 0.999 0.000
Y54.7 Agents affecting calcification
0.001 0.999 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.001 0.999 0.000
Y54.5 Other diuretics
0.001 0.999 0.000
Y54.4 Loop [high-ceiling] diuretics
0.001 0.999 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.001 0.999 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.001 0.999 0.000
Y54.0 Mineralocorticoids
0.001 0.999 0.000
S92.00 Fracture of calcaneus (closed)
0.001 0.999 0.000
R68.8 Other specified general symptoms and signs
0.000 0.999 0.001
T45.5 Anticoagulants
0.001 0.999 0.000
Y40.7 Antifungal antibiotics, systemically used
0.001 0.999 0.000
Y40.6 Rifamycins
0.001 0.999 0.000
Y40.5 Aminoglycosides
0.001 0.999 0.000
Y40.4 Tetracyclines
0.001 0.999 0.000
Y40.2 Chloramphenicol group
0.001 0.999 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.001 0.999 0.000
Y44.7 Plasma substitutes
0.001 0.999 0.000
Y44.6 Natural blood and blood products
0.001 0.999 0.000
Y44.5 Thrombolytic drugs
0.001 0.999 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.001 0.999 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.001 0.999 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.001 0.999 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.001 0.999 0.000
Y57.5 X-ray contrast media
0.001 0.999 0.000
Z43.9 Attention to unspecified artificial opening
0.001 0.999 0.000
Z43.8 Attention to other artificial openings
0.001 0.999 0.000
Z43.7 Attention to artificial vagina
0.001 0.999 0.000
Z43.0 Attention to tracheostomy
0.001 0.999 0.000
K74.5 Biliary cirrhosis, unspecified
0.001 0.999 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.001 0.999 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.001 0.999 0.000
T37.5 Antiviral drugs
0.001 0.999 0.000
T37.4 Anthelminthics
0.001 0.999 0.000
T37.3 Other antiprotozoal drugs
0.001 0.999 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.001 0.999 0.000
T37.1 Antimycobacterial drugs
0.001 0.999 0.000
T37.0 Sulphonamides
0.001 0.999 0.000
T38.9 Other and unspecified hormone antagonists
0.001 0.999 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.001 0.999 0.000
T38.7 Androgens and anabolic congeners
0.001 0.999 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.001 0.999 0.000
T38.5 Other oestrogens and progestogens
0.001 0.999 0.000
T38.4 Oral contraceptives
0.001 0.999 0.000
T38.2 Antithyroid drugs
0.001 0.999 0.000
T38.1 Thyroid hormones and substitutes
0.001 0.999 0.000
T38.0 Glucocorticoids and synthetic analogues
0.001 0.999 0.000
T41.5 Therapeutic gases
0.001 0.999 0.000
T41.4 Anaesthetic, unspecified
0.001 0.999 0.000
T41.3 Local anaesthetics
0.001 0.999 0.000
T41.2 Other and unspecified general anaesthetics
0.001 0.999 0.000
T41.1 Intravenous anaesthetics
0.001 0.999 0.000
T41.0 Inhaled anaesthetics
0.001 0.999 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.001 0.999 0.000
T45.8 Other primarily systemic and haematological agents
0.001 0.999 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.001 0.999 0.000
T45.6 Fibrinolysis-affecting drugs
0.001 0.999 0.000
T45.4 Iron and its compounds
0.001 0.999 0.000
T45.3 Enzymes, not elsewhere classified
0.001 0.999 0.000
T45.2 Vitamins, not elsewhere classified
0.001 0.999 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.001 0.999 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.001 0.999 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.001 0.999 0.000
T48.5 Anti-common-cold drugs
0.001 0.999 0.000
T48.4 Expectorants
0.001 0.999 0.000
T48.3 Antitussives
0.001 0.999 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.001 0.999 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.001 0.999 0.000
T48.0 Oxytocic drugs
0.001 0.999 0.000
T49.9 Topical agent, unspecified
0.001 0.999 0.000
T49.8 Other topical agents
0.001 0.999 0.000
T49.7 Dental drugs, topically applied
0.001 0.999 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.001 0.999 0.000
T49.5 Ophthalmological drugs and preparations
0.001 0.999 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.001 0.999 0.000
T49.3 Emollients, demulcents and protectants
0.001 0.999 0.000
T49.2 Local astringents and local detergents
0.001 0.999 0.000
T49.1 Antipruritics
0.001 0.999 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.001 0.999 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.001 0.999 0.000
N08 Glomerular disorders in diseases classified elsewhere
0.000 0.999 0.001
H10.9 Conjunctivitis, unspecified
0.000 0.999 0.001
N17.0 Acute renal failure with tubular necrosis
0.000 0.999 0.001
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.001 0.999 0.000
T45.0 Antiallergic and antiemetic drugs
0.001 0.999 0.000
W22.9 Unspecified place
0.001 0.999 0.000
Z43.4 Attention to other artificial openings of digestive tract
0.001 0.999 0.000
F42.9 Obsessive-compulsive disorder, unspecified
0.001 0.999 0.000
I61.9 Intracerebral haemorrhage, unspecified
0.000 0.999 0.001
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.001 0.999 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.001 0.999 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.001 0.999 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.001 0.999 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.001 0.999 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.001 0.999 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.001 0.999 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.001 0.999 0.000
T44.0 Anticholinesterase agents
0.001 0.999 0.000
Y40.3 Macrolides
0.001 0.999 0.000
Z43.6 Attention to other artificial openings of urinary tract
0.001 0.999 0.000
Z43.5 Attention to cyctostomy
0.001 0.999 0.000
C45 Mesothelioma
0.001 0.999 0.000
Z08 Follow-up examination after treatment for malignant neoplasm
0.001 0.999 0.000
S92.10 Fracture of talus (closed)
0.001 0.999 0.000
C18.6 Descending colon
0.001 0.999 0.000
I87.2 Venous insufficiency (chronic) (peripheral)
0.001 0.999 0.000
J93.9 Pneumothorax, unspecified
0.001 0.999 0.000
L03.0 Cellulitis of finger and toe
0.000 0.999 0.001
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.001 0.999 0.000
K70-K77 Diseases of liver
0.001 0.999 0.000
H66.1 Chronic tubotympanic suppurative otitis media
0.001 0.999 0.000
K31.8 Other specified diseases of stomach and duodenum
0.000 0.999 0.001
K72.0 Acute and subacute hepatic failure
0.001 0.999 0.000
N17.8 Other acute renal failure
0.000 0.999 0.001
N17.2 Acute renal failure with medullary necrosis
0.000 0.999 0.001
N17.1 Acute renal failure with acute cortical necrosis
0.000 0.999 0.001
T43.5 Other and unspecified antipsychotics and neuroleptics
0.001 0.999 0.000
T50.8 Diagnostic agents
0.001 0.999 0.000
T50.7 Analeptics and opioid receptor antagonists
0.001 0.999 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.001 0.999 0.000
T50.5 Appetite depressants
0.001 0.999 0.000
T50.4 Drugs affecting uric acid metabolism
0.001 0.999 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.001 0.999 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.001 0.999 0.000
T50.1 Loop [high-ceiling] diuretics
0.001 0.999 0.000
T50.0 Mineralocorticoids and their antagonists
0.001 0.999 0.000
Y40.9 Systemic antibiotic, unspecified
0.001 0.999 0.000
K72 Hepatic failure, not elsewhere classified
0.001 0.999 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.001 0.999 0.000
S02.10 Fracture of base of skull (closed)
0.000 0.999 0.001
S92.30 Fracture of metatarsal bone (closed)
0.001 0.999 0.000
J93.8 Other pneumothorax
0.001 0.999 0.000
K74 Fibrosis and cirrhosis of liver
0.001 0.999 0.000
S92.40 Fracture of great toe (closed)
0.001 0.999 0.000
K52.8 Other specified non-infective gastro-enteritis and colitis
0.000 0.999 0.001
N08.8 Glomerular disorders in other diseases classified elsewhere
0.000 0.999 0.001
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases
0.000 0.999 0.001
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism
0.000 0.999 0.001
N08.1 Glomerular disorders in neoplastic diseases
0.000 0.999 0.001
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere
0.000 0.999 0.001
S92.0 Fracture of calcaneus
0.001 0.999 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.001 0.999 0.000
E11.0 With coma
0.000 0.999 0.001
F42.0 Predominantly obsessional thoughts or ruminations
0.001 0.999 0.000
K70 Alcoholic liver disease
0.001 0.999 0.000
B97.8 Other viral agents as the cause of diseases classified to other chapters
0.001 0.999 0.000
C45.2 Mesothelioma of pericardium
0.001 0.999 0.000
C45.1 Mesothelioma of peritoneum
0.001 0.999 0.000
D12.0 Caecum
0.001 0.999 0.000
F43.1 Posttraumatic stress disorder
0.001 0.999 0.000
K70.4 Alcoholic hepatic failure
0.001 0.999 0.000
S82.2 Fracture of shaft of tibia
0.000 0.999 0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.